Medical Editor: John P. Cunha, DO, FACOEP
Temovate (clobetasol propionate) Scalp Application, 0.05% is a topical steroid used to treat inflammation and itching caused by skin conditions such as allergic reactions, eczema, and psoriasis. Temovate Scalp Application is available in generic form. Common side effects of Temovate Scalp Application include mild skin rash, itchy skin, burning/stinging or redness, dry or cracking skin, thinning or softening of your skin, swollen hair follicles, temporary hair loss, spider veins, changes in the color of treated skin, skin rash or irritation around your mouth, blisters, pimples, crusting of treated skin, and stretch marks.
Temovate should be applied in a twice-daily dose for no more than two consecutive weeks. Do not exceed 50 mL of Temovate in a single week. Do not cover treated area of skin unless directed to do so by your doctor. Talk to your doctor before giving Temovate to a child. Prolonged topical steroid use in children can cause a delay in growth. Temovate may interact with other drugs. Tell your doctor all medications you use. Do not use Temovate if you are pregnant or breastfeeding.
Our Temovate (clobetasol propionate) Scalp Application, 0.05% Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Although the risk of serious side effects is low when clobetasol topical is applied to the skin, you should be aware of side effects that can occur if the medication is absorbed into your bloodstream.
Stop using this medication and call your doctor at once if you have severe irritation of any treated skin, or if you show signs of absorbing clobetasol topical through your skin, such as:
- blurred vision, or seeing halos around lights;
- mood changes;
- sleep problems (insomnia);
- weight gain, puffiness in your face; or
- muscle weakness, feeling tired.
Less serious side effects may include:
- mild skin rash, itching, burning, or redness;
- dry or cracking skin;
- thinning or softening of your skin;
- skin rash or irritation around your mouth;
- swollen hair follicles;
- temporary hair loss;
- spider veins;
- changes in color of treated skin;
- blisters, pimples, or crusting of treated skin; or
- stretch marks.
This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.
Read the entire detailed patient monograph for Temovate Scalp (Clobetasol Propionate Scalp Application)
TEMOVATE Scalp (clobetasol propionate scalp application) Application is generally well tolerated when used for 2-week treatment periods.
The most frequent adverse events reported for TEMOVATE Scalp (clobetasol propionate scalp application) Application have been local and have included burning and/or stinging sensation, which occurred in 29 of 294 patients; scalp pustules, which occurred in 3 of 294 patients; and tingling and folliculitis, each of which occurred in 2 of 294 patients. Less frequent adverse events were itching and tightness of the scalp, dermatitis, tenderness, headache, hair loss, and eye irritation, each of which occurred in 1 of 294 patients.
The following local adverse reactions are reported infrequently when topical corticosteroids are used as recommended. These reactions are listed in an approximately decreasing order of occurrence: burning, itching, irritation, dryness, folliculitis, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, maceration of the skin, secondary infection, skin atrophy, striae, and miliaria. Systemic absorption of topical corticosteroids has produced reversible HPA axis suppression, manifestations of Cushing's syndrome, hyperglycemia, and glucosuria in some patients. In rare instances, treatment (or withdrawal of treatment) of psoriasis with corticosteroids is thought to have exacerbated the disease or provoked the pustular form of the disease, so careful patient supervision is recommended.
Read the entire FDA prescribing information for Temovate Scalp (Clobetasol Propionate Scalp Application)
© Temovate Scalp Patient Information is supplied by Cerner Multum, Inc. and Temovate Scalp Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.